Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-β/Smad in HepG2 cell

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 2, 2010, Pages 420-426

  Liu, Xin ^c   Yang, Yan ^a,c   Zhang, Xiaoxiang ^b   Xu, Shengxin ^a   He, Shufang ^a   Huang, Weijuan ^a   Roberts, Michael S ^c  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b HEFEI UNIVERSITY OF TECHNOLOGY   (China)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Compound Astragalus and Salvia miltiorrhiza extract (CASE); Experimental hepatocarcinogenesis; Hepatocellular carcinoma treatment; HepG2 cells; Smad; Transforming growth factor

Indexed keywords

ASTRAGALOSIDE; ASTRAGALUS EXTRACT; ASTRAGALUS POLYSACCHARIDE; PLANT GLYCOSIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SALVIA MILTIORRHIZA EXTRACT; SALVIANOLIC ACID; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG MECHANISM; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SALVIA MILTIORRHIZA; TALUS; WESTERN BLOTTING;

EID: 76149111103     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05981.x     Document Type: Article

References (29)

1. Matsuzaki K. Modulation of TGF-beta signaling during progression of chronic liver diseases. Front Biosci. 2009 14 : 2923 2934.
2. Ranganathan P, Agrawal A, Bhushan R et al. Expression profiling of genes regulated by TGF-beta: differential regulation in normal and tumour cells. BMC Genomics. 2007 8 : 98.
3. Chen CJ, Yang HI, Su J et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006 295 : 65 73.
4. Okuda H. Hepatocellular carcinoma development in cirrhosis. Best Pract. Res. Clin. Gastroenterol. 2007 21 : 161 173.
5. Matsuzaki K, Okazaki K. Transforming growth factor-beta during carcinogenesis: the shift from epithelial to mesenchymal signaling. J. Gastroenterol. 2006 41 : 295 303. (Pubitemid 43834371)
6. Tahashi Y, Matsuzaki K, Date M et al. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 2002 35 : 49 61.
7. Furukawa F, Matsuzaki K, Mori S et al. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology 2003 38 : 879 889.
8. Mikula M, Proell V, Fischer AN, Mikulits W. Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-beta dependent fashion. J. Cell. Physiol. 2006 209 : 560 567.
9. Cho WC, Leung KN. In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett. 2007 252 : 43 54.
10. Cui R, He J, Wang B et al. Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats. Cancer Chem. Pharmacol. 2003 51 : 75 80. (Pubitemid 36057026)
11. Chen L, Huang J. Review on the research of the effect of danshen and its extract on tumor metastasis. J. Zhejiang Univ. Tradit. Chin. Med. (Chin.) 2006 30 : 449 452.
12. Sun J, Zhou X, Liu Y. Study on preventive and therapeutic effect of radix salviae miltiorrhizae on recurrence and metastasis of liver cancer Zhongguo Zhong Xi Yi Jie He Za Zhi (Chin.) 1999 19 : 292 295.
13. Yang Y, Yang S, Chen M, Zhang X, Zou Y, Zhang X. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts. J. Ethnopharmacol. 2008 118 : 264 270.
14. Matsuzaki K, Date M, Furukawa F et al. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth. Hepatology 2000 32 : 218 227.
15. Kim MM, Ta QV, Mendis E et al. Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity. Life Sci. 2006 79 : 1436 1443.
16. Mori S, Matsuzaki K, Yoshida K et al. TGF-beta and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions. Oncogene 2004 23 : 7416 7429.
17. Matsuzaki K, Date M, Furukawa F et al. Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma. Cancer Res. 2000 60 : 1394 1402.
18. Yang C, Zeisberg M, Lively JC, Nyberg P, Afdhal N, Kalluri R. Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res. 2003 63 : 8312 8317.
19. Eduardo FD, Bueno DF, de Freitas PM et al. Stem cell proliferation under low intensity laser irradiation: a preliminary study. Lasers Surg. Med. 2008 40 : 433 438.
20. Zhang H, Ozaki I, Mizuta T et al. Transforming growth factor-beta 1-induced apoptosis is blocked by beta 1-integrin-mediated mitogen-activated protein kinase activation in human hepatoma cells. Cancer Sci. 2004 95 : 878 886.
21. Elliott RL, Blobe GC. Role of transforming growth factor Beta in human cancer. J. Clin. Oncol. 2005 23 : 2078 2093.
22. Pardali K, Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys Acta 2007 1775 : 21 62.
23. Sekimoto G, Matsuzaki K, Yoshida K et al. Reversible smad-dependent signaling between tumor suppression and oncogenesis. Cancer Res. 2007 67 : 5090 5096.
24. Prunier C, Mazars A, Noe V et al. Evidence that Smad2 is a tumor suppressor implicated in the control of cellular invasion. J. Biochem. 1999 274 : 22919 22922.
25. Subramanian G, Schwarz RE, Higgins L et al. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Cancer Res. 2004 64 : 5200 5211.
26. Gaspar NJ, Li L, Kapoun AM et al. Inhibition of transforming growth factor β signaling reduces pancreatic adenocarcinoma growth and invasiveness. Mol. Pharmacol. 2007 72 : 152 161.
27. Kaminska B, Wesolowska A, Danilkiewicz M. TGF beta signalling and its role in tumour pathogenesis. Acta Biochim. Pol. 2005 52 : 329 337.
28. Blanchette F, Rivard N, Rudd P, Grondin F, Attisano L, Dubois CM. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation. J. Biol. Chem. 2001 276 : 33986 33994.
29. Matsuzaki K, Murata M, Yoshida K et al. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology 2007 46 : 48 57.